LOS ANGELES, Nov. 26, 2008 (GLOBE NEWSWIRE) -- Khang & Khang LLP today announced it is investigating potential claims against KV Pharmaceutical Company ("KV Pharmaceutical" or the "Company")(NYSE:KV-A) (NYSE:KV-B) concerning possible securities violations arising from public statements made by the Company between February 15, 2008 and November 12, 2008. The investigation pertains to allegations that certain public statements made by the Company during that period failed to disclose, among other things, violations of Food and Drug Administration regulations and other compliance matters and management misconduct.
If you purchased shares of KV Pharmaceutical between February 15, 2008 and November 12, 2008, or if you would like to learn more about these claims or have information about the allegations, or if you wish to discuss these matters or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Joon M. Khang, Esquire, of Khang & Khang LLP, 1901 Avenue of the Stars, 2nd Floor, Los Angeles, California 90067, or by telephone at (310) 461-1342, or by email to Joon@Khanglaw.com.